Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma

Yi Jen Chen, Jan Gowth Chang, Li Sun Shih, Pao Huei Chen, Mitsuo Endo, Jacqueline Whang-Peng, Yi Ming A. Chen

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The tumor-suppressor gene CDKN2 (p16/INK4A/MTSI) is frequently altered in human gastric-cancer cell lines. However, mutation of the CDKN2 gene in primary human gastric-carcinoma tissues as seen through genomic DNA analysis has rarely been reported. In this study, a method combining reverse transcription and nested polymerase chain reaction was developed to detect different RNA transcripts of the CDKN2 gene in human gastric cancers. The results showed that, besides the wild-type CDKN2 transcript, 5 of 11 (45.5%) diffuse-type and 3 of 10 (30%) intestinal-type primary gastric adenocarcinoma had aberrant CDKN2 RNA transcripts. Among these 8 tumorous specimens with abnormal CDKN2 RNA transcripts, 6 had intragenic deletions of part of both CDKN2 exons 1 and 2, including 1 case which had an additional inserted sequence from part of CDKN2 intron 2. In addition, 1 case had a deletion of part of CDKN2 exon 1 and 1 case had its entire exon 2 deleted. In contrast, matched normal gastric mucosal tissues from the same patients did not have any aberrant CDKN2 RNA transcript. Furthermore, CDKN2 exon 1 or 2 genomic DNA from all the gastric-carcinoma tissues were PCR-amplified and sequenced and no genetic alteration was detected. Therefore, alteration and heterozygous expression of CDKN2 appears to be involved in the pathogenesis of human gastric cancers.

Original languageEnglish
Pages (from-to)350-354
Number of pages5
JournalInternational Journal of Cancer
Volume71
Issue number3
DOIs
Publication statusPublished - Jun 9 1997
Externally publishedYes

Fingerprint

p16 Genes
Exons
Stomach
Adenocarcinoma
RNA
Stomach Neoplasms
Cyclin-Dependent Kinase Inhibitor p16
Carcinoma
Polymerase Chain Reaction
DNA
Tumor Suppressor Genes
Introns
Reverse Transcription
Mucous Membrane
Cell Line
Mutation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma. / Chen, Yi Jen; Chang, Jan Gowth; Shih, Li Sun; Chen, Pao Huei; Endo, Mitsuo; Whang-Peng, Jacqueline; Chen, Yi Ming A.

In: International Journal of Cancer, Vol. 71, No. 3, 09.06.1997, p. 350-354.

Research output: Contribution to journalArticle

Chen, Yi Jen ; Chang, Jan Gowth ; Shih, Li Sun ; Chen, Pao Huei ; Endo, Mitsuo ; Whang-Peng, Jacqueline ; Chen, Yi Ming A. / Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma. In: International Journal of Cancer. 1997 ; Vol. 71, No. 3. pp. 350-354.
@article{582408b4f4b34ab98c6f88a8f6bcbc47,
title = "Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma",
abstract = "The tumor-suppressor gene CDKN2 (p16/INK4A/MTSI) is frequently altered in human gastric-cancer cell lines. However, mutation of the CDKN2 gene in primary human gastric-carcinoma tissues as seen through genomic DNA analysis has rarely been reported. In this study, a method combining reverse transcription and nested polymerase chain reaction was developed to detect different RNA transcripts of the CDKN2 gene in human gastric cancers. The results showed that, besides the wild-type CDKN2 transcript, 5 of 11 (45.5{\%}) diffuse-type and 3 of 10 (30{\%}) intestinal-type primary gastric adenocarcinoma had aberrant CDKN2 RNA transcripts. Among these 8 tumorous specimens with abnormal CDKN2 RNA transcripts, 6 had intragenic deletions of part of both CDKN2 exons 1 and 2, including 1 case which had an additional inserted sequence from part of CDKN2 intron 2. In addition, 1 case had a deletion of part of CDKN2 exon 1 and 1 case had its entire exon 2 deleted. In contrast, matched normal gastric mucosal tissues from the same patients did not have any aberrant CDKN2 RNA transcript. Furthermore, CDKN2 exon 1 or 2 genomic DNA from all the gastric-carcinoma tissues were PCR-amplified and sequenced and no genetic alteration was detected. Therefore, alteration and heterozygous expression of CDKN2 appears to be involved in the pathogenesis of human gastric cancers.",
author = "Chen, {Yi Jen} and Chang, {Jan Gowth} and Shih, {Li Sun} and Chen, {Pao Huei} and Mitsuo Endo and Jacqueline Whang-Peng and Chen, {Yi Ming A.}",
year = "1997",
month = "6",
day = "9",
doi = "10.1002/(SICI)1097-0215(19970502)71:3<350::AID-IJC7>3.0.CO;2-X",
language = "English",
volume = "71",
pages = "350--354",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma

AU - Chen, Yi Jen

AU - Chang, Jan Gowth

AU - Shih, Li Sun

AU - Chen, Pao Huei

AU - Endo, Mitsuo

AU - Whang-Peng, Jacqueline

AU - Chen, Yi Ming A.

PY - 1997/6/9

Y1 - 1997/6/9

N2 - The tumor-suppressor gene CDKN2 (p16/INK4A/MTSI) is frequently altered in human gastric-cancer cell lines. However, mutation of the CDKN2 gene in primary human gastric-carcinoma tissues as seen through genomic DNA analysis has rarely been reported. In this study, a method combining reverse transcription and nested polymerase chain reaction was developed to detect different RNA transcripts of the CDKN2 gene in human gastric cancers. The results showed that, besides the wild-type CDKN2 transcript, 5 of 11 (45.5%) diffuse-type and 3 of 10 (30%) intestinal-type primary gastric adenocarcinoma had aberrant CDKN2 RNA transcripts. Among these 8 tumorous specimens with abnormal CDKN2 RNA transcripts, 6 had intragenic deletions of part of both CDKN2 exons 1 and 2, including 1 case which had an additional inserted sequence from part of CDKN2 intron 2. In addition, 1 case had a deletion of part of CDKN2 exon 1 and 1 case had its entire exon 2 deleted. In contrast, matched normal gastric mucosal tissues from the same patients did not have any aberrant CDKN2 RNA transcript. Furthermore, CDKN2 exon 1 or 2 genomic DNA from all the gastric-carcinoma tissues were PCR-amplified and sequenced and no genetic alteration was detected. Therefore, alteration and heterozygous expression of CDKN2 appears to be involved in the pathogenesis of human gastric cancers.

AB - The tumor-suppressor gene CDKN2 (p16/INK4A/MTSI) is frequently altered in human gastric-cancer cell lines. However, mutation of the CDKN2 gene in primary human gastric-carcinoma tissues as seen through genomic DNA analysis has rarely been reported. In this study, a method combining reverse transcription and nested polymerase chain reaction was developed to detect different RNA transcripts of the CDKN2 gene in human gastric cancers. The results showed that, besides the wild-type CDKN2 transcript, 5 of 11 (45.5%) diffuse-type and 3 of 10 (30%) intestinal-type primary gastric adenocarcinoma had aberrant CDKN2 RNA transcripts. Among these 8 tumorous specimens with abnormal CDKN2 RNA transcripts, 6 had intragenic deletions of part of both CDKN2 exons 1 and 2, including 1 case which had an additional inserted sequence from part of CDKN2 intron 2. In addition, 1 case had a deletion of part of CDKN2 exon 1 and 1 case had its entire exon 2 deleted. In contrast, matched normal gastric mucosal tissues from the same patients did not have any aberrant CDKN2 RNA transcript. Furthermore, CDKN2 exon 1 or 2 genomic DNA from all the gastric-carcinoma tissues were PCR-amplified and sequenced and no genetic alteration was detected. Therefore, alteration and heterozygous expression of CDKN2 appears to be involved in the pathogenesis of human gastric cancers.

UR - http://www.scopus.com/inward/record.url?scp=0030970326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030970326&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19970502)71:3<350::AID-IJC7>3.0.CO;2-X

DO - 10.1002/(SICI)1097-0215(19970502)71:3<350::AID-IJC7>3.0.CO;2-X

M3 - Article

VL - 71

SP - 350

EP - 354

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 3

ER -